← Back to headlines
Lilly Reports Positive Results for Gene Editing Cholesterol Therapy
Pharmaceutical company Lilly announced that its gene editing therapy successfully reduced 'bad' cholesterol levels in an early-stage clinical trial.
26 May, 11:33 — 26 May, 11:33
Sources
Showing 1 of 1 sources
